Autopsy report · NCT03216187

Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery

“insufficient funding and recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 6 years 11 months before it stopped.
• 126 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Benno Rehberg-Klug

Sponsor type

University, hospital or other

Conditions

Persistent Postoperative Pain

Interventions

Pregabalin; Placebos

Participants

126

Sites

6

Countries

Switzerland

Trials that died the same way

• Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
  “Low recruitment, insufficient funding” (96% match in meaning)
• Probiotic Lactobacillus GG to Eliminate VRE Colonization
  “Insufficient recruitment, no additional funding available” (94% match in meaning)
• Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
  “Difficulty in recruitment and funding.” (87% match in meaning)
• Reach Out and Read Arabic to Promote Arabic Literacy in Toddlers
  “Poor recruitment and lack of funding” (86% match in meaning)
• Effect of Antibiotics on Urinary Microbiome
  “funding , recruitment issues” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.